ArticleClinical pharmacokinetics2020

Inability of Current Dosing to Achieve Carboplatin Therapeutic Targets in People with Advanced Non-Small Cell Lung Cancer: Impact of Systemic Inflammation on Carboplatin Exposure and Clinical Outcomes.

Benjamin D W Harris et al.PubMed ↗Publisher ↗

No numbers read from the abstract.